Auxogyn, Inc. is advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The company’s first product, the non-invasive Early Embryo Viability Assessment System (Eeva), provides quantitative information regarding embryo development, to assist IVF clinics in potentially selecting the best embryo(s) for transfer and optimizing the treatment path for their patients undergoing in vitro fertilization (IVF) procedures.
View Top Employees from Auxogyn, Inc.Website | http://auxogyn.com |
Revenue | $8 million |
Employees | 3 (3 on RocketReach) |
Founded | 2008 |
Address | 1490 O'BRIEN Dr., Ste. A, Menlo Park, California 94025, US |
Phone | (650) 641-2429 |
Industry | Biotechnology, Pharmaceuticals, Healthcare |
Web Rank | 22 Million |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Auxogyn, Inc. employee's phone or email?
The Auxogyn, Inc. annual revenue was $8 million in 2023.
3 people are employed at Auxogyn, Inc..
Auxogyn, Inc. is based in Menlo Park, California.
The NAICS codes for Auxogyn, Inc. are [3254, 325, 32].
The SIC codes for Auxogyn, Inc. are [28, 283].